intravenous T900607-sodium

DRUG3 trials

Sponsors

Tularik

Conditions

Hepatocellular CarcinomaNon-Hodgkin's LymphomaOvarian Neoplasms

Phase 2

Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer.

TularikOvarian Neoplasms

Start: 2002-07-31Target: 35Updated: 2005-06-24

Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma.

TerminatedNCT00043459

TularikNon-Hodgkin's Lymphoma

Start: 2002-07-31End: 2003-03-31Target: 35Updated: 2005-06-24

Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma.

TularikHepatocellular Carcinoma

Start: 2002-07-31Target: 35Updated: 2005-06-24